About 2nd Proteome- Targeted Drug Discovery Summit
Accelerating Small Molecule Drug Discovery Programs By Uniting Experts From Throughout Industry To Target The Entire Proteome
Why should you attend the 2nd Proteome-Targeted Drug Discovery Summit?
Utilize next-generation chemical biology platforms for novel target target identification with insights from Biogen, Merck & AstraZeneca
Expand the druggable proteome through next-generation screening platforms, with insight from GSK, PhoreMost & Ribon Therapeutics
Leverage innovative chemical probes to accelerate fragment-based lead generation, with insights from Novartis & The Weizmann Institute of Science
Harness structure-based computational technologies to successfully target protein-protein interactions, with insights from RAPT Therapeutics
Give rise to novel therapeutic modalities to drug the undruggable, with insights from Silicon Therapeutics & AbbVie